![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/4174 | (2006.01) |
A61P 31/16 | (2006.01) |
(11) | Number of the document | 1802302 |
(13) | Kind of document | T |
(96) | European patent application number | 05784163.7 |
Date of filing the European patent application | 2005-09-16 | |
(97) | Date of publication of the European application | 2007-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
(46) | Date of publication of the claims translation | 2017-02-10 |
(86) | Number | PCT/EP2005/010026 |
Date | 2005-09-16 |
(87) | Number | WO 2006/037452 |
Date | 2006-04-13 |
(30) | Number | Date | Country code |
102004049008 | 2004-10-05 | DE |
(72) |
SACHER, Fritz, DE
TSCHAIKIN, Marion, DE
KOELSCH, Stephan, DE
|
(73) |
The Procter & Gamble Company,
One Procter & Gamble Plaza, Cincinnati, OH 45202,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | LFA-simpatomimetikų, turinčių 2-imidazolino struktūra, naujas panaudojimas |
NOVEL USE OF alpha-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE |
Payment date | Validity (years) | Amount | |
2018-08-23 | 14 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2019-09-16 |